Lacktman Quoted on New Telemedicine Laws in Oklahoma, Texas
August 2, 2017
Bloomberg BNA
Partner Nate Lacktman was quoted in a Bloomberg BNA article, “New State Telemedicine Laws Show Provider Hurdles Remain,” covering the pros and cons of the new telemedicine laws in Oklahoma and Texas, and the evolution of telemedicine as a whole.
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
Lacktman said, “Although there is relative consistency and homogeneity in how state laws define the ‘practice of medicine,’ state law definitions of telemedicine are varied, as are state telemedicine practice standards. Telemedicine providers would benefit if state legislatures and medical boards used consistent definitions, such as the model language contained in the Federation of State Medical Boards’ [Model Policy for the Appropriate Use of Telemedicine Technologies].”
“There is an evolution at play for telemedicine regulation,” he continued later. “When we started, most states had no telemedicine rules, and providers asked for laws that affirmatively stated ‘yes, you may use telemedicine.’ A decade later, providers are asking to make those same rules less onerous and more flexible.”
People
Related News
January 15, 2026
In the News
Kyle Faget Assesses Regulatory Shifts Impacting Medtech
Foley & Lardner LLP partner Kyle Faget is featured in four Medtech Insight articles evaluating the medtech industry’s major developments in 2025 and examining 2026 regulatory challenges.
January 14, 2026
In the News
James Lundy on Stakes for Securities Industry as Disgorgement Case Heads to SCOTUS
Foley & Lardner LLP partner James Lundy addressed the impact a ruling from the U.S. Supreme Court would have on the securities industry in the Law360, “SEC To Lean On Congress As Defense In High Court Case.”
January 14, 2026
In the News
Natasha Allen on Companies Navigating AI Regulations – 'The issue right now is timing'
Foley & Lardner LLP partner Natasha Allen shared insight on how companies are navigating AI regulations in the Silicon Valley Business Journal article, “Silicon Valley companies navigate AI adoption as state and federal rules remain uncertain.”